183 related articles for article (PubMed ID: 26724872)
1. [Appropriate prescription, adherence and safety of non-steroidal anti-inflammatory drugs].
Sostres C; Lanas Á
Med Clin (Barc); 2016 Mar; 146(6):267-72. PubMed ID: 26724872
[TBL] [Abstract][Full Text] [Related]
2. Strategies to optimize treatment with NSAIDs in patients at risk for gastrointestinal and cardiovascular adverse events.
Scheiman JM; Hindley CE
Clin Ther; 2010 Apr; 32(4):667-77. PubMed ID: 20435236
[TBL] [Abstract][Full Text] [Related]
3. Minimizing risks of NSAIDs: cardiovascular, gastrointestinal and renal.
Davies NM; Reynolds JK; Undeberg MR; Gates BJ; Ohgami Y; Vega-Villa KR
Expert Rev Neurother; 2006 Nov; 6(11):1643-55. PubMed ID: 17144779
[TBL] [Abstract][Full Text] [Related]
4. [Safe prescription recommendations for non steroidal anti-inflammatory drugs: Consensus document ellaborated by nominated experts of three scientific associations (SER-SEC-AEG)].
Lanas A; Benito P; Alonso J; Hernández-Cruz B; Barón-Esquivias G; Perez-Aísa A; Calvet X; García-Llorente JF; Gobbo M; Gonzalez-Juanatey JR
Gastroenterol Hepatol; 2014 Mar; 37(3):107-27. PubMed ID: 24529572
[TBL] [Abstract][Full Text] [Related]
5. [Profile of prescription and adequacy of treatment with non-steroidal anti-inflammatory drugs in diabetic patients].
Navarro-Martínez A; Vidal-Martínez M; García-Rosa I; Lázaro-Gómez MJ; Brotons-Román J
Rev Calid Asist; 2015; 30(5):256-64. PubMed ID: 26346581
[TBL] [Abstract][Full Text] [Related]
6. A regional audit of the use of COX-2 selective non-steroidal anti-inflammatory drugs (NSAIDs) in rheumatology clinics in the West Midlands, in relation to NICE guidelines.
Price-Forbes AN; Callaghan R; Allen ME; Rowe IF
Rheumatology (Oxford); 2005 Jul; 44(7):921-4. PubMed ID: 15827035
[TBL] [Abstract][Full Text] [Related]
7. Canadian consensus guidelines on long-term nonsteroidal anti-inflammatory drug therapy and the need for gastroprotection: benefits versus risks.
Rostom A; Moayyedi P; Hunt R;
Aliment Pharmacol Ther; 2009 Mar; 29(5):481-96. PubMed ID: 19053986
[TBL] [Abstract][Full Text] [Related]
8. The role of dose reduction with NSAID use.
Matthews ML
Am J Manag Care; 2013 Nov; 19(14 Suppl):s273-7. PubMed ID: 24494606
[TBL] [Abstract][Full Text] [Related]
9. Safe prescription recommendations for non steroidal anti-inflammatory drugs: consensus document ellaborated by nominated experts of three scientific associations (SER-SEC-AEG).
Lanas A; Benito P; Alonso J; Hernández-Cruz B; Barón-Esquivias G; Perez-Aísa Á; Calvet X; García-Llorente JF; Gobbo M; Gonzalez-Juanatey JR; ; ;
Reumatol Clin; 2014; 10(2):68-84. PubMed ID: 24462644
[TBL] [Abstract][Full Text] [Related]
10. Nonsteroidal anti-inflammatory drugs, gastroprotection, and benefit-risk.
Moore RA; Derry S; Simon LS; Emery P
Pain Pract; 2014 Apr; 14(4):378-95. PubMed ID: 23941628
[TBL] [Abstract][Full Text] [Related]
11. Nonsteroidal anti-inflammatory drugs (NSAIDs), cyxlooxygenase-2 selective inhibitors (coxibs) and gastrointestinal harm: review of clinical trials and clinical practice.
Moore RA; Derry S; Phillips CJ; McQuay HJ
BMC Musculoskelet Disord; 2006 Oct; 7():79. PubMed ID: 17054784
[TBL] [Abstract][Full Text] [Related]
12. Management of patients on nonsteroidal anti-inflammatory drugs: a clinical practice recommendation from the First International Working Party on Gastrointestinal and Cardiovascular Effects of Nonsteroidal Anti-inflammatory Drugs and Anti-platelet Agents.
Chan FK; Abraham NS; Scheiman JM; Laine L;
Am J Gastroenterol; 2008 Nov; 103(11):2908-18. PubMed ID: 18853980
[TBL] [Abstract][Full Text] [Related]
13. Non-Steroidal anti inflammatory drugs usage in orthopaedics and trauma practice. A guide and review.
Eyichukwu GO
Niger J Med; 2010; 19(4):374-81. PubMed ID: 21526623
[TBL] [Abstract][Full Text] [Related]
14. [Clinical guidelines «Rational use of nonsteroidal anti-inflammatory drugs (NSAIDs) in clinical practice». Part II].
Group of authors
Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(5):94-99. PubMed ID: 26356169
[No Abstract] [Full Text] [Related]
15. Cardiovascular disease and non-steroidal anti-inflammatory drug prescribing in the midst of evolving guidelines.
Pham TT; Miller MJ; Harrison DL; Lloyd AE; Crosby KM; Johnson JL
J Eval Clin Pract; 2013 Dec; 19(6):1026-34. PubMed ID: 23163341
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of differences between indication and prescription of gastroprotection in patients with risk factors treated with nonsteroidal anti-inflammatory agents: the GAP study].
Lanas A; Muñoz M; Caballero Correa M; Martínez Jiménez P;
Gastroenterol Hepatol; 2010 Feb; 33(2):80-91. PubMed ID: 19931944
[TBL] [Abstract][Full Text] [Related]
17. Are COX-2 inhibitors preferable to non-selective non-steroidal anti-inflammatory drugs in patients with risk of cardiovascular events taking low-dose aspirin?
Strand V
Lancet; 2007 Dec; 370(9605):2138-51. PubMed ID: 18156036
[TBL] [Abstract][Full Text] [Related]
18. Adverse effects of non-steroidal anti-inflammatory drugs (NSAIDs, aspirin and coxibs) on upper gastrointestinal tract.
Sostres C; Gargallo CJ; Arroyo MT; Lanas A
Best Pract Res Clin Gastroenterol; 2010 Apr; 24(2):121-32. PubMed ID: 20227026
[TBL] [Abstract][Full Text] [Related]
19. Practical approaches to minimizing gastrointestinal and cardiovascular safety concerns with COX-2 inhibitors and NSAIDs.
Scheiman JM; Fendrick AM
Arthritis Res Ther; 2005; 7 Suppl 4(Suppl 4):S23-9. PubMed ID: 16168078
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular safety of non-steroidal anti-inflammatory drugs among healthy individuals.
Fosbøl EL; Køber L; Torp-Pedersen C; Gislason GH
Expert Opin Drug Saf; 2010 Nov; 9(6):893-903. PubMed ID: 20569079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
